Molecular analysis of AmpC-producing Escherichia coli isolated from pediatric patients
Journal of the Pediatric Infectious Diseases Society · 2025
DOI: 10.1093/jpids/piaf008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2025. Verfasst von Eiki Ogawa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. Hauptthemen laut MEDLINE: beta-Lactamases, Escherichia coli, Escherichia coli Infections, Bacterial Proteins. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
AmpC-mediated cephalosporin resistance occurs in 1.0% to 3.3% of Escherichia coli isolates due to the production of either plasmid-mediated AmpC (p-AmpC) or chromosomal AmpC (c-AmpC). Data on the prevalence and molecular characteristics of AmpC-producing E. coli in pediatric patients are limited.
Methods
We analyzed E. coli clinical strains with resistance phenotype consistent with AmpC production isolated from patients at a pediatric hospital in Japan between 2015 and 2022. Sequence types, resistance genes, and relevant mutations were identified through whole genome sequencing. Promoter and attenuator regions of the chromosomal ampC gene were examined, and the presence of plasmid-mediated ampC genes was determined.
Results
Among 2081 E. coli strains, 80 (3.8%) from 27 patients demonstrated the AmpC phenotype. The median patient age was 55 months, with 92.6% having underlying diseases, mainly renal and urinary tract abnormalities. Of the 27 strains, p-AmpC was found in 9 strains including 6 strains belonging to ST131, while c-AmpC was identified in 18 strains including 9 ST73 strains and 4 ST12 strains.ST131 and ST73 were the major AmpC-E. coli lineages isolated from children with underlying diseases.
Conclusions
Most ST131 strains harbored p-ampC, while all ST73 strains acquired cephalosporin resistance by c-AmpC production through promoter and attenuator mutations, suggesting the presence of both AmpC mechanisms in a lineage-specific manner in E. coli identified among hospitalized children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
- Department of General Pediatrics, Aichi Children's Health and Medical Center, Aichi, Japan.
- Department of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
- Center for Innovative Antimicrobial Therapy, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
ORCID-Profile: Eiki Ogawa
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Ogawa, E., Suzuki, M., Sakurai, A., & Doi, Y. (2025). Molecular analysis of AmpC-producing Escherichia coli isolated from pediatric patients. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piaf008
Vancouver
Ogawa E, Suzuki M, Sakurai A, Doi Y. Molecular analysis of AmpC-producing Escherichia coli isolated from pediatric patients. Journal of the Pediatric Infectious Diseases Society. 2025. doi:10.1093/jpids/piaf008
BibTeX
@article{Ogawa2025,
author = {Ogawa, Eiki and Suzuki, Masahiro and Sakurai, Aki and Doi, Yohei},
title = {Molecular analysis of AmpC-producing Escherichia coli isolated from pediatric patients},
journal = {Journal of the Pediatric Infectious Diseases Society},
year = {2025},
doi = {10.1093/jpids/piaf008}
}
EUVIMED